AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Ovarian cancer

152
Clinical Trials
17
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT02324439
Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
Completed · Phase 1
NCT02311907
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Completed · Phase 3
NCT02311907
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Completed · Phase 3
📊 Sample Meta-Analyses
CRD42020193978
Rhizoma Chuanxiong based-Chinese Medicine Therapy for Taxanes-Induced Peripheral Neurotoxicity:A Systemic Review and Meta-Analysis
Taxanes-derived agents such as paclitaxel and docetaxel are chemotherapy drugs w
CRD42019122314
Calcium intake and health outcomes: an umbrella review of meta-analyses of observational and interventional studies
Health outcomes that seem to be related with calcium obtaining will be studied i
CRD42019125271
Systematic review and meta-analysis of vitamin D/calcium and risk of ovarian cancer
The risk of ovarian cancer.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Ovarian cancer
🏥 Names
Disease Name
Ovarian cancer
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Ovarian cancer
topic type
disease
tcmsp disease id
597

🌿 Related Herbs

1 · contains this compound

🧬 Gene / Protein Targets

3 · genes implicated in this disease
EGFR
Gene EGFR
Heat shock protein HSP 90
Stromelysin-1

📋 Clinical Trials

12 · subject of clinical study
NCT02324439 Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
→ Epithelial Ovarian Cancer|Fallopian Tube Cancer|Pr
NCT02311907 Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carbopl
→ Chemotherapeutic Agent Toxicity|Neuropathy|Neuroto
NCT02311907 Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carbopl
→ Chemotherapeutic Agent Toxicity|Neuropathy|Neuroto
NCT00091377 Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurr
→ Fallopian Tube Cancer|Ovarian Cancer|Primary Perit
NCT00091377 Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurr
→ Fallopian Tube Cancer|Ovarian Cancer|Primary Perit
NCT00382811 OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With an
→ Fallopian Tube Cancer|Peritoneal Neoplasms|Ovarian
NCT00001383 A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC
→ Breast Cancer|Cancer|Carcinoma, Renal Cell|Lymphom
NCT00002717 Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian
→ Ovarian Cancer|Primary Peritoneal Cavity Cancer
NCT00002734 Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Pa
→ Ovarian Cancer|Primary Peritoneal Cavity Cancer
NCT00002894 Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With
→ Ovarian Cancer|Primary Peritoneal Cavity Cancer
NCT00002928 Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian C
→ Ovarian Cancer
NCT00003120 S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or
→ Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Ca

📊 Meta-Analyses

12 · systematic review
CRD42020193978 Rhizoma Chuanxiong based-Chinese Medicine Therapy for Taxanes-Induced Peripheral
→ Taxanes-derived agents such as paclitaxel and doce
CRD42019122314 Calcium intake and health outcomes: an umbrella review of meta-analyses of obser
→ Health outcomes that seem to be related with calci
CRD42019125271 Systematic review and meta-analysis of vitamin D/calcium and risk of ovarian can
→ The risk of ovarian cancer.
CRD42019125271 Systematic review and meta-analysis of vitamin D/calcium and risk of ovarian can
→ The risk of ovarian cancer.
CRD42020157420 Association between vitamin D/calcium intake and 25-hydroxyvitamin D and risk of
→ According to the global cancer data 2018, there we
CRD42020157420 Association between vitamin D/calcium intake and 25-hydroxyvitamin D and risk of
→ According to the global cancer data 2018, there we
CRD42022368330 Dietary exposure to cadmium and risk of breast, endometrial, and ovarian cancers
→ Breast, endometrial, and ovarian cancers are the m
CRD42020166740 Effect of shikonin on the proliferation and apoptosis of human ovarian cancer ce
→ shikonin; human ovarian cancer cell SKOV3
CRD42020170501 A protocol of systematic review and meta-analysis of shikonin on the proliferati
→ shikonin; human ovarian cancer cell SKOV3
CRD42022356472 Comprehensive Systematic Review and Meta-Analysis of the association between Sel
→ The association between selenium and Epithelial Ov
CRD42013003555 Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedi
→ This review will focus on people who have recurren
CRD42020187622 Weekly versus 3-weekly paclitaxel in combination with carboplatin in ovarian can
→ Paclitaxel is used as a chemotherapy drug to treat
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables